Codetta Bio develops a digital spatial platform that integrates digital PCR and qPCR technologies for the multiplex measurement of blood-based protein biomarkers. This platform reduces analysis time from two days to two hours, enhancing the sensitivity and efficiency of multi-omics assays in translational research and clinical applications.
Funding
$27.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for measuring blood-based protein biomarkers often involve lengthy analysis times and require multiple instruments to analyze different omics, creating bottlenecks in translational research and clinical applications. Existing technologies may also lack the sensitivity needed for early detection of biomarkers present at low concentrations.
Solution
Codetta Bio has developed the Concerto System, an integrated digital spatial platform that combines digital PCR and qPCR technologies for multiplex measurement of protein, DNA, and RNA biomarkers from a single sample. The platform utilizes microbead-based target capture and a blend of digital PCR, real-time PCR, and immunoPCR to deliver high-sensitivity and high-throughput results. This approach reduces analysis time from days to hours and enables the simultaneous analysis of multiple omics from a single instrument, accelerating translational programs and enhancing the efficiency of biomarker analysis.
Target Audience
The primary target audience includes translational researchers and clinical laboratories involved in vaccine development, neurology, cell and gene therapy, infectious disease, liquid biopsy, oncology, gene editing, and immunology.
Features
- Integrated platform for protein, DNA, and RNA biomarker analysis
- Combines digital PCR and qPCR for enhanced sensitivity and dynamic range
- Microbead-based target capture for efficient biomarker detection
- Multiplexing capability for simultaneous measurement of multiple biomarkers
- Reduced analysis time from 2 days to 2 hours
- Streamlined workflow with a single instrument